Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma

Yetirajam Rajesh; Angana Biswas; Payel Banik; Ipsita Pal; Subhayan Das; Sachin A. Borkar; Hardik Sardana; Abhijit Saha; Swadesh K. Das; Luni Emdad; Paul B. Fisher; Mahitosh Mandal

doi:10.18632/oncotarget.27425

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Priority Research Papers:

Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma

Yetirajam Rajesh, Angana Biswas, Payel Banik, Ipsita Pal, Subhayan Das, Sachin A. Borkar, Hardik Sardana, Abhijit Saha, Swadesh K. Das, Luni Emdad, Paul B. Fisher _ and Mahitosh Mandal _

PDF | Full Text | Supplementary Files | How to cite | Press Release

Oncotarget. 2020; 11:1097-1108. https://doi.org/10.18632/oncotarget.27425

Metrics: PDF 1853 views | Full Text 2015 views | ?

Abstract

Yetirajam Rajesh1, Angana Biswas1, Payel Banik1, Ipsita Pal1, Subhayan Das1, Sachin A. Borkar2, Hardik Sardana2, Abhijit Saha3, Swadesh K. Das4^,5^,6, Luni Emdad4^,5^,6, Paul B. Fisher4^,5^,6 and Mahitosh Mandal1^,4^,5

1 School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India

2 Department of Neurosurgery & Gamma Knife, All India Institute of Medical Sciences, New Delhi, India

3 Radiation Department, UGC DAE Consortium, Jadavpur University, Kolkata, India

4 Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA

5 VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA

6 VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA

Correspondence to:

Mahitosh Mandal,	email:	[email protected]
Paul B. Fisher,	email:	[email protected]

Keywords: HSPB1; RNAseq; Fli-1; radioresistant GBM; temozolomide resistant GBM

Received: November 11, 2019 Accepted: December 21, 2019 Published: March 31, 2020

ABSTRACT

Glioblastoma (GBM) is the most common primary brain tumor and is invariably fatal. Heat shock proteins (HSPs) provide protein signatures/biomarkers for GBM that afford potential as targets for developing anti-GBM drugs. In GBM, elevated expression of hypoxia inducible factors under the influence of Ets family proteins significantly promotes the expression of HSPs. RNAseq analysis identified HSPB1 as a prominent upregulated HSP in GBM and in radiation resistant/temozolomide resistant (radio/TMZR) GBM. Here, we established friend leukemia integration 1 (Fli-1), a member of Ets family to be playing a transcriptional regulatory role on the HSPB1 gene. Fli-1 binds to nucleotide residues GGAA at binding sites 3, 6 and 7 in the 5-kb upstream region of HSPB1. Fli-1 has been linked to oncogenic transformation with upregulation in radio/TMZR GBM. Overexpression of Fli-1 in GBM promotes resistance, whereas Fli-1 knockdown in radio/TMZR GBM cells suppresses resistance. We identify the underlying molecular mechanisms of Fli-1-mediated regulation of HSPB1 that drive extracellular matrix remodeling and epithelial to mesenchymal transition in radio/TMZR GBM cells. This study uncovers Fli-1 as a potential therapeutic target for combating radiation and temozolomide resistance in GBM.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27425

Publication Alerts

Priority Research Papers:

Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma

Abstract